Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

HPV and Gynecologic Cancer

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Cancer Epidemiol Biomarkers Prev.

Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ

doi: 10.1158/1055-9965.EPI-20-1003.

HPV and Gynecologic Cancer

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Am J Obstet Gynecol.

Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM

doi: 10.1016/j.ajog.2020.08.026.

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

HPV and Gynecologic Cancer

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

JAMA Intern Med.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS

doi: 10.1001/jamainternmed.

HPV and Gynecologic Cancer

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

JAMA.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB

doi: 10.1001/jama.2018.10897.

HPV and Gynecologic Cancer

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Br J Cancer.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J

doi: 10.1038/bjc.2017.371.

HPV and Gynecologic Cancer

Genetic variations in human papillomavirus and cervical cancer outcomes

Int J Cancer.

Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ

doi: 10.1002/ijc.32038.

HPV and Gynecologic Cancer

Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study

Lancet Glob Health.

Abbas KM, van Zandvoort K, Brisson M, Jit M

doi: 10.1016/S2214-109X(20)30022-X.

HPV and Gynecologic Cancer

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Br J Cancer.

Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J

doi: 10.1038/s41416-018-0053-6.

Related content

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Genetic variations in human papillomavirus and cervical cancer outcomes

Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer